Company / Current Assets
CRESCENT BIOPHARMA, INC. Current Assets History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$236.7M
FY2025
5-year range
$40.5M / $236.7M
FY2021-FY2025
Trend
+86.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $41M to $237M over the past 9 years.
Based on SEC 10-K filings.
$237M in FY2025 with a 10-year CAGR of +17.5%.
Improved from $41M to $237M over the past 9 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +17.5%
Key checks
Key Insights
- In FY2025, current assets increased 86.0% year-over-year.
- Lowest current assets in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $236.7M | +86.0% |
| FY2017 | $127.2M | +214.0% |
| FY2016 | $40.5M | -14.2% |
| FY2015 | $47.2M | -15.8% |
| FY2014 | $56.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026